Related Experiment Video
Updated: Sep 26, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice
M Breuer1, R Slebos, S Verbeek
1Division of Molecular Genetics, the Netherlands Cancer Institute, Amsterdam.
Abstract:
Infection of mice with Moloney murine leukaemia virus (MuLV) induces T-cell lymphomas after an average latency period of 150 days. In these lymphomas the MuLV DNA is frequently integrated into the mouse chromosomal DNA in the vicinity of the pim-1 oncogene. Transgenic mice overexpressing the pim-1 oncogene are predisposed to develop T-cell lymphomas, but only to the extent that approximately 10% of the mice develop a lymphoma within 240 days. When these mice are infected with MuLV, lymphomas develop in all mice in only 50-60 days. In these lymphomas MuLV DNA is integrated near either the c-myc or N-myc gene, suggesting that pim-1 and myc synergize in lymphomagenesis. To determine whether this system has a more general application, we have now tested the susceptibility of pim-1 transgenic mice to N-ethyl-N-nitrosourea (ENU), a chemical carcinogen. With a single low dose of ENU, nearly all pim-1 transgenic mice, but only 15% of non-transgenic mice, develop T-cell lymphomas within 200 days. All ENU-induced lymphomas in both pim-1 transgenic and non-transgenic mice express high levels of c-myc messenger RNA, supporting the notion that pim-1 and c-myc synergize in lymphoma induction. We propose that pim-1 transgenic mice could be used to test the oncogenic potential of other chemical compounds.
Insights
Moloney murine leukaemia virus (MuLV) and N-ethyl-N-nitrosourea (ENU) accelerate T-cell lymphoma development in pim-1 transgenic mice. These findings suggest pim-1 and c-myc oncogenes synergize in lymphoma induction.
Area of Science:
- Oncology
- Virology
- Genetics
Background:
- Moloney murine leukaemia virus (MuLV) infection causes T-cell lymphomas in mice with a long latency period.
- The pim-1 oncogene is often found near MuLV DNA integrations in these lymphomas.
- Transgenic mice overexpressing pim-1 are predisposed to T-cell lymphomas, but viral infection significantly shortens latency.
Purpose of the Study:
- To investigate the synergistic role of pim-1 and myc oncogenes in lymphomagenesis.
- To evaluate the utility of pim-1 transgenic mice for assessing chemical carcinogen oncogenic potential.
Main Methods:
- Infection of pim-1 transgenic and non-transgenic mice with MuLV.
- Administration of a single low dose of the chemical carcinogen N-ethyl-N-nitrosourea (ENU) to pim-1 transgenic and non-transgenic mice.
- Analysis of lymphoma development, latency periods, and oncogene expression (pim-1, c-myc, N-myc) in induced tumors.
Main Results:
- MuLV infection in pim-1 transgenic mice led to rapid T-cell lymphoma development in all mice, with MuLV DNA integrating near c-myc or N-myc.
- ENU exposure induced T-cell lymphomas in nearly all pim-1 transgenic mice, compared to only 15% of non-transgenic controls, within 200 days.
- All induced lymphomas, regardless of genotype or induction method, showed high c-myc messenger RNA levels, supporting pim-1 and c-myc synergy.
Conclusions:
- The pim-1 oncogene synergizes with c-myc in the induction of T-cell lymphomas.
- Pim-1 transgenic mice serve as a sensitive model for evaluating the oncogenic potential of chemical compounds.
- This model system advances our understanding of lymphomagenesis and offers a platform for carcinogenicity testing.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)